Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess Bioavailability
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Study to Assess the Pharmacokinetics of R406 in Healthy Subjects when Fostamatinib 150 mg is
Administered Alone in Fed and Fasted state and in Combination with Ranitidine in Fasted
State, and to Assess the Relative Bioavailability of Process Variants of Tablets